10 mg (30s count)
Simvastatin
Product Images NDC 65727-068
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Simvastatin (NDC 65727-068). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Biocon Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
20 mg (30s count)
This is a medication label for Simvastatin Tablets, USP containing 20mg of the drug. It is manufactured by Biocon and comes in a bottle of 30 tablets. No further information can be gathered from the given text.*
40 mg (30s count)
5 mg (30s count)
Biocon produces a medication called Simvastatin which comes in the form of tablets. These tablets are available in a 5mg strength and come in bottles of 30 tablets. The NDC number for this medication is 65727-065-12 and it is only available by prescription. The other parts of the text are not available or readable.*
80 mg (30s count)
Figure 9 (Simvastatin 10)
Table2 (Simvastatin 2)
The table shows adverse reactions reported by patients treated with Simvastatin, where the percentage of patients experiencing each reaction is equal to or greater than 2% and greater than placebo in 45. The reactions are grouped by body system, and examples of reactions include Edema/swelling, abdominal pain, atrial fibrillation, constipation, myalgia, headache, and eczema.*
Structure (Simvastatin 3)
Table 3 (Simvastatin 4)
This is a chart showing the effect of co-administered drugs or grapefruit juice on the systemic exposure of Simvastatin, a medication used to treat high cholesterol. The chart provides information on the dosing and ratios of various drugs or grapefruit juice when taken with Simvastatin, as well as the geometric mean ratio of each combination. There is also information provided on dosing adjustments required for specific drugs and the contraindications and warnings associated with taking Simvastatin with certain drugs or grapefruit juice.*
Table 4 (Simvastatin 5)
Figure 5 (Simvastatin 6)
Figure 6 (Simvastatin 7)
Figure 7 (Simvastatin 8)
Figure 8 (Simvastatin 9)
Table 1 (Table 1)
This text provides a list of drug interactions that are associated with an increased risk of myopathy/rhabdomyolysis. Included are interacting agents and prescribing recommendations, emphasizing the importance of not exceeding certain dosages when taking certain drugs, and even listing which drugs should be avoided altogether if taking simvastatin. Furthermore, grapefruit juice is also listed as something to avoid.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
